In vitro and in vivo characterisation of [11C]-DASB:: a probe for in vivo measurements of the serotonin transporter by positron emission tomography

被引:136
作者
Wilson, AA
Ginovart, N
Hussey, D
Meyer, J
Houle, S
机构
[1] Univ Toronto, CAMH, PET Ctr, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada
关键词
serotonin transporter; PET; carbon-11; DASB; in vivo imaging;
D O I
10.1016/S0969-8051(02)00316-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
3-Amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile, labeled with carbon-11 ([Cl-11-DASB), is a recently introduced radiotracer for imaging the serotonin transporter (SERT) by positron emission tomography (PET). A series of in vitro and in vivo experiments were performed to further characterise the properties of [C-11]-DASB as an in vivo imaging agent for SERT. In vitro binding assays confirmed that DASB binds specifically to SERT,kith nanomolar affinity and high selectivity over a large number of other receptors, ion-channels and enzymes in the central nervous system. Ex vivo, [C-11]-DASB binding in rat brain was shown to be saturable (ED50 of 56 nmoles/kg). and sensitive to both the number of available SERT binding sites and the number of viable serotonin neurons. Estimates of the radiation dose in man were extrapolated from rat biodistribution data effective dose 5.5 E-03 mSv/MBq; critical organ-urinary bladder wall). Together with previous studies, the present findings indicate that [C-11]-DASB is a very useful radiopharmaceutical for probing changes in SERT densities using PET imaging in the living human brain, (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:509 / 515
页数:7
相关论文
共 24 条
[1]  
Acton PD, 2001, J NUCL MED, V42, P1556
[2]   LIGANDS AND TRACERS FOR PET STUDIES OF THE 5-HT SYSTEM - CURRENT STATUS [J].
CROUZEL, C ;
GUILLAUME, M ;
BARRE, L ;
LEMAIRE, C ;
PIKE, VW .
NUCLEAR MEDICINE AND BIOLOGY, 1992, 19 (08) :857-870
[3]   AUTORADIOGRAPHIC LOCALIZATION OF H-3 PAROXETINE-LABELED SEROTONIN UPTAKE SITES IN RAT-BRAIN [J].
DESOUZA, EB ;
KUYATT, BL .
SYNAPSE, 1987, 1 (05) :488-496
[4]   Sensitivity of new radiopharmaceuticals [J].
Eckelman, WC .
NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (03) :169-173
[5]   Positron emission tomography quantification of [11C]-DASB binding to the human serotonin transporter:: Modeling strategies [J].
Ginovart, N ;
Wilson, AA ;
Meyer, JH ;
Hussey, D ;
Houle, S .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (11) :1342-1353
[6]  
GINOVART N, 2001, 12 INT S RAD INT CH
[7]   Imaging the serotonin transporter with positron emission tomography:: initial human studies with [11C]DAPP and [11C]DASB [J].
Houle, S ;
Ginovart, N ;
Hussey, D ;
Meyer, JH ;
Wilson, AA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (11) :1719-1722
[8]  
HUANG Y, 2001, J NUCL MED, V42, pS392
[9]   Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals [J].
Hume, SP ;
Gunn, RN ;
Jones, T .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (02) :173-176
[10]   Time-dependent recovery of in vivo binding sites after drug dosing: A method for radiotracer evaluation [J].
Kilbourn, MR .
NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (01) :115-118